These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 30639418)

  • 1. Primary cardiac manifestation of autosomal dominant polycystic kidney disease revealed by patient induced pluripotent stem cell-derived cardiomyocytes.
    Lee JJ; Cheng SJ; Huang CY; Chen CY; Feng L; Hwang DY; Kamp TJ; Chen HC; Hsieh PCH
    EBioMedicine; 2019 Feb; 40():675-684. PubMed ID: 30639418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Batch Variations in Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes from 2 Major Suppliers.
    Huo J; Kamalakar A; Yang X; Word B; Stockbridge N; Lyn-Cook B; Pang L
    Toxicol Sci; 2017 Mar; 156(1):25-38. PubMed ID: 28031415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of special autosomal dominant polycystic kidney disease iPSCs with the capability of functional kidney-like cell differentiation.
    Huang J; Zhou S; Niu X; Hu B; Li Q; Zhang F; Zhang X; Cai X; Lou Y; Liu F; Xu C; Wang Y
    Stem Cell Res Ther; 2017 Sep; 8(1):196. PubMed ID: 28927462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient carrying a PKD1 Q533X mutation.
    Lee JJ; Ho MC; Huang CY; Wen CH; Cheng YC; Hsu YH; Hwang DY; Lu HE; Chen HC; Hsieh PCH
    Stem Cell Res; 2017 Dec; 25():83-87. PubMed ID: 29121521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses.
    Preininger MK; Jha R; Maxwell JT; Wu Q; Singh M; Wang B; Dalal A; Mceachin ZT; Rossoll W; Hales CM; Fischbach PS; Wagner MB; Xu C
    Dis Model Mech; 2016 Sep; 9(9):927-39. PubMed ID: 27491078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation-specific differences in arrhythmias and drug responses in CPVT patients: simultaneous patch clamp and video imaging of iPSC derived cardiomyocytes.
    Pölönen RP; Swan H; Aalto-Setälä K
    Mol Biol Rep; 2020 Feb; 47(2):1067-1077. PubMed ID: 31786768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations.
    Kujala K; Paavola J; Lahti A; Larsson K; Pekkanen-Mattila M; Viitasalo M; Lahtinen AM; Toivonen L; Kontula K; Swan H; Laine M; Silvennoinen O; Aalto-Setälä K
    PLoS One; 2012; 7(9):e44660. PubMed ID: 22962621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of an induced pluripotent stem cell line, IBMS-iPSC-014-05, from a female autosomal dominant polycystic kidney disease patient carrying a common mutation of R803X in PKD2.
    Ho MC; Huang CY; Lee JJ; Hsu SH; Cheng YC; Hsu YH; Hwang DY; Lu HE; Chen HC; Hsieh PCH
    Stem Cell Res; 2017 Dec; 25():38-41. PubMed ID: 29055226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic renal-epithelial derived induced pluripotent stem cells from polycystic kidney disease patients.
    Kenter AT; Rentmeester E; van Riet J; Boers R; Boers J; Ghazvini M; Xavier VJ; van Leenders GJLH; Verhagen PCMS; van Til ME; Eussen B; Losekoot M; de Klein A; Peters DJM; van IJcken WFJ; van de Werken HJG; Zietse R; Hoorn EJ; Jansen G; Gribnau JH
    Stem Cells Transl Med; 2020 Apr; 9(4):478-490. PubMed ID: 32163234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating
    Shemer Y; Mekies LN; Ben Jehuda R; Baskin P; Shulman R; Eisen B; Regev D; Arbustini E; Gerull B; Gherghiceanu M; Gottlieb E; Arad M; Binah O
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360639
    [No Abstract]   [Full Text] [Related]  

  • 11. Patient-Specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia.
    Sasaki K; Makiyama T; Yoshida Y; Wuriyanghai Y; Kamakura T; Nishiuchi S; Hayano M; Harita T; Yamamoto Y; Kohjitani H; Hirose S; Chen J; Kawamura M; Ohno S; Itoh H; Takeuchi A; Matsuoka S; Miura M; Sumitomo N; Horie M; Yamanaka S; Kimura T
    PLoS One; 2016; 11(10):e0164795. PubMed ID: 27764147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations.
    Freedman BS; Lam AQ; Sundsbak JL; Iatrino R; Su X; Koon SJ; Wu M; Daheron L; Harris PC; Zhou J; Bonventre JV
    J Am Soc Nephrol; 2013 Oct; 24(10):1571-86. PubMed ID: 24009235
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Kuraoka S; Tanigawa S; Taguchi A; Hotta A; Nakazato H; Osafune K; Kobayashi A; Nishinakamura R
    J Am Soc Nephrol; 2020 Oct; 31(10):2355-2371. PubMed ID: 32747355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome.
    Guo F; Sun Y; Wang X; Wang H; Wang J; Gong T; Chen X; Zhang P; Su L; Fu G; Su J; Yang S; Lai R; Jiang C; Liang P
    Circ Res; 2019 Jan; 124(1):66-78. PubMed ID: 30582453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revealing potential cardiac manifestation of ADPKD using iPS cell-derived cardiomyocytes.
    Morizane R
    EBioMedicine; 2019 Feb; 40():19-20. PubMed ID: 30711518
    [No Abstract]   [Full Text] [Related]  

  • 16. Generation of human induced pluripotent stem cell line (MUi026-A) from a patient with autosomal dominant polycystic kidney disease carrying PKD1 point mutation.
    Maneepitasut W; Wongkummool W; Tong-Ngam P; Promthep K; Tubsuwan A; Khine Linn A; Phakdeekitcharoen B; Borwornpinyo S; Kitiyanant N; Phanthong P; Hongeng S
    Stem Cell Res; 2021 May; 53():102306. PubMed ID: 33799277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human iPSC modelling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes.
    Benzoni P; Campostrini G; Landi S; Bertini V; Marchina E; Iascone M; Ahlberg G; Olesen MS; Crescini E; Mora C; Bisleri G; Muneretto C; Ronca R; Presta M; Poliani PL; Piovani G; Verardi R; Di Pasquale E; Consiglio A; Raya A; Torre E; Lodrini AM; Milanesi R; Rocchetti M; Baruscotti M; DiFrancesco D; Memo M; Barbuti A; Dell'Era P
    Cardiovasc Res; 2020 May; 116(6):1147-1160. PubMed ID: 31504264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome.
    Liang P; Sallam K; Wu H; Li Y; Itzhaki I; Garg P; Zhang Y; Vermglinchan V; Lan F; Gu M; Gong T; Zhuge Y; He C; Ebert AD; Sanchez-Freire V; Churko J; Hu S; Sharma A; Lam CK; Scheinman MM; Bers DM; Wu JC
    J Am Coll Cardiol; 2016 Nov; 68(19):2086-2096. PubMed ID: 27810048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with MYL2-R58Q-Mediated Apical Hypertrophic Cardiomyopathy Show Hypertrophy, Myofibrillar Disarray, and Calcium Perturbations.
    Zhou W; Bos JM; Ye D; Tester DJ; Hrstka S; Maleszewski JJ; Ommen SR; Nishimura RA; Schaff HV; Kim CS; Ackerman MJ
    J Cardiovasc Transl Res; 2019 Oct; 12(5):394-403. PubMed ID: 30796699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease.
    Chebib FT; Jung Y; Heyer CM; Irazabal MV; Hogan MC; Harris PC; Torres VE; El-Zoghby ZM
    Nephrol Dial Transplant; 2016 Jun; 31(6):952-60. PubMed ID: 26932689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.